CN1840132A - Tablet for treating climacteric syndrome - Google Patents

Tablet for treating climacteric syndrome Download PDF

Info

Publication number
CN1840132A
CN1840132A CN 200610008436 CN200610008436A CN1840132A CN 1840132 A CN1840132 A CN 1840132A CN 200610008436 CN200610008436 CN 200610008436 CN 200610008436 A CN200610008436 A CN 200610008436A CN 1840132 A CN1840132 A CN 1840132A
Authority
CN
China
Prior art keywords
raw materials
magnesium stearate
time
tablet
rhizoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200610008436
Other languages
Chinese (zh)
Inventor
端智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200610008436 priority Critical patent/CN1840132A/en
Publication of CN1840132A publication Critical patent/CN1840132A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a tablet preparation for treating women's climacteric metancholia, wherein the formula includes cardamorn 170-200g, Siberian solomonseal rhizome, asparagus root, mace nutmeg, linaloe, clove, rhizoma gymnadeniae each 25-45g, starch 10-25g, magnesium stearate 7-15g. Its preparing process is also disclosed in the invention.

Description

Tablet for treating climacteric syndrome
One, technical field: the invention belongs to the Tibetan medicine technical field, particularly a kind of tablet for treating climacteric syndrome that is used for climacteric syndrome with QI and blood regulating, heart tonifying and tranquilizing function.
Two, technical background: the medicine that is used for climacteric syndrome that has QI and blood regulating, heart tonifying and tranquilizing function in the market has pill, tablet, but their result of use is all undesirable, but also has the big deficiency of toxic and side effects.
Three, summary of the invention:
The objective of the invention is to develop a kind of tablet for treating climacteric syndrome at the prior art above shortcomings.This tablet has the effect of invigorating QI and tranquilization, QI and blood regulating, and it is applicable to the emotional lability that climacteric syndrome causes, psychentonia, and dysphoria, dizzy weak, the insomnia and dreamful sleep disease.
Technical scheme is: this tablet for treating climacteric syndrome is made by following proportioning raw materials and manufacture method: (one) proportioning raw materials is the quality weight ratio, Fructus Amomi Rotundus 170~200g, Rhizoma Polygonati 25~45g, Radix Asparagi 25~45g, Semen Myristicae 25~45g, Lignum Aquilariae Resinatum 25~45g, Flos Caryophylli 25~45g, Rhizoma Gymnadeniae 25~45g, starch 10~25g, magnesium stearate 7~15g; (2) manufacture method is: above-mentioned raw materials is pressed the above-mentioned raw materials proportion ingredient, Fructus Amomi Rotundus, Rhizoma Polygonati, Radix Asparagi, the Rhizoma Gymnadeniae mixing and water adding decocts 2~3 times, decocted 1.5~2.5 hours for the first time, for the second time, respectively decocted for the third time 0.5~1.5 hour, collecting decoction, filter cleaner, filtrate concentrates anhydrates that to make thick paste standby, with Lignum Aquilariae Resinatum, Flos Caryophylli, three kinds of pulverizing medicinal materials of Semen Myristicae become fine powder, again with thick paste mix homogeneously, drying, after the pulverizing, after the screening of 〉=80 mesh standard sieves, the siftage fine powder is made granule with ethanol, adds starch more after drying, magnesium stearate mixing tabletting gets product.Thick paste is meant bigger than the water content of extractum, in order that be convenient to add Lignum Aquilariae Resinatum, Flos Caryophylli, myristic fine powder.
Tablet of the present invention, it is unique to have a prescription, and processing technology has effectively been utilized the useful composition of medical material, and dosage is accurate, and constant product quality is difficult for going mouldy, and carries, advantage such as taking convenience.Every day 2~3 times when taking, each 2~4.
Four, the specific embodiment:
Embodiment one: get Fructus Amomi Rotundus 170g, Rhizoma Polygonati, Radix Asparagi, Semen Myristicae, each 25g of Lignum Aquilariae Resinatum, Flos Caryophylli 45g, Rhizoma Gymnadeniae 45g, starch 10g, magnesium stearate 7g prepares burden, Fructus Amomi Rotundus, Rhizoma Polygonati, Radix Asparagi, the Rhizoma Gymnadeniae mixing and water adding decocts 2 times, decocted 2.5 hours for the first time, decocted 1.5 hours for the second time, collecting decoction filters filtrate concentrating and anhydrates that to make thick paste standby, Lignum Aquilariae Resinatum, Flos Caryophylli, three kinds of pulverizing medicinal materials of Semen Myristicae become fine powder, with thick paste mixing, drying, after the pulverizing, after the screening of 80 mesh standard sieves, sieve fine powder ethanol content down is that 10% ethanol is made granule, adds starch more after drying, magnesium stearate mixing tabletting gets product.
Embodiment two; Get Fructus Amomi Rotundus 200g, Rhizoma Polygonati, Radix Asparagi, Semen Myristicae, each 45g of Lignum Aquilariae Resinatum, Flos Caryophylli 25g, Rhizoma Gymnadeniae 25g, starch 25g, magnesium stearate 15g prepares burden, Fructus Amomi Rotundus, Rhizoma Polygonati, Radix Asparagi, the Rhizoma Gymnadeniae mixing and water adding decocts 3 times, decocted 1.5 hours for the first time, second, respectively decocted for the third time 0.5 hour, collecting decoction filters filtrate concentrating and anhydrates that to make thick paste standby, Lignum Aquilariae Resinatum, Flos Caryophylli, three kinds of pulverizing medicinal materials of Semen Myristicae become fine powder, again with extractum mixing, drying, after the pulverizing, after the screening of 100 purpose standard screens, the fine powder ethanol content is 60% alcohol granulation under the sieve, adds starch after drying, magnesium stearate mixing tabletting gets product.
Embodiment three: get Fructus Amomi Rotundus 1.75kg, and Rhizoma Polygonati, Radix Asparagi, Semen Myristicae, Lignum Aquilariae Resinatum, Flos Caryophylli, each 0.35kg of Rhizoma Gymnadeniae, starch 0.15kg, magnesium stearate 0.10kg prepares burden, and the manufacture method of back is identical with embodiment two.

Claims (1)

1. tablet for treating climacteric syndrome, it is characterized in that it is made by following proportioning raw materials and manufacture method: (one) proportioning raw materials is the quality weight ratio, Fructus Amomi Rotundus 170~200g, Rhizoma Polygonati 25~45g, Radix Asparagi 25~45g, Semen Myristicae 25~45g, Lignum Aquilariae Resinatum 25~45g, Flos Caryophylli 25~45g, Rhizoma Gymnadeniae 25~45g, starch 10~25g, magnesium stearate 7~15g; (2) manufacture method is: above-mentioned raw materials is pressed the above-mentioned raw materials proportion ingredient, Fructus Amomi Rotundus, Rhizoma Polygonati, Radix Asparagi, the Rhizoma Gymnadeniae mixing and water adding decocts 2~3 times, decocted 1.5~2.5 hours for the first time, for the second time, respectively decocted for the third time 0.5~1.5 hour, collecting decoction, filter cleaner, filtrate concentrates anhydrates that to make thick paste standby, with Lignum Aquilariae Resinatum, Flos Caryophylli, three kinds of pulverizing medicinal materials of Semen Myristicae become fine powder, again with thick paste mix homogeneously, drying, after the pulverizing, after the screening of 〉=80 mesh standard sieves, the siftage fine powder is made granule with ethanol, adds starch more after drying, magnesium stearate mixing tabletting gets product.
CN 200610008436 2006-01-21 2006-01-21 Tablet for treating climacteric syndrome Pending CN1840132A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200610008436 CN1840132A (en) 2006-01-21 2006-01-21 Tablet for treating climacteric syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200610008436 CN1840132A (en) 2006-01-21 2006-01-21 Tablet for treating climacteric syndrome

Publications (1)

Publication Number Publication Date
CN1840132A true CN1840132A (en) 2006-10-04

Family

ID=37029435

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200610008436 Pending CN1840132A (en) 2006-01-21 2006-01-21 Tablet for treating climacteric syndrome

Country Status (1)

Country Link
CN (1) CN1840132A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111068019A (en) * 2019-11-22 2020-04-28 内蒙古民族大学 Mongolian medicine composition and its action and application

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111068019A (en) * 2019-11-22 2020-04-28 内蒙古民族大学 Mongolian medicine composition and its action and application

Similar Documents

Publication Publication Date Title
CN1840133A (en) Six-ingredient tablet containing pomegranate
CN102138604A (en) Blood activating and menstruation normalizing tea
CN107801999A (en) A kind of folium cortex eucommiae buccal tablet with vasorelaxation action
CN101129193B (en) Compound high calcium tablet of yak medulla and method of preparing the same
CN100367940C (en) Funingkang thin-coating tablet and preparing method
CN100518770C (en) Preparation of kidney-tonifying health-care tablet by micropowder technology
CN102302609A (en) Compound traditional Chinese drug preparation for improving subhealth
CN1840134A (en) Capsule for treating climacteric syndrome
CN101966261B (en) Medicament for treating high blood pressure and preparation method thereof
CN115137770B (en) Preparation method of traditional Chinese medicine product with efficacy of reducing blood fat and blood pressure
CN1839981A (en) Gynecological inflammation resisting dispersion tablet and its preparation method
CN101642480A (en) Pseudo-ginseng flower leaf oral tablet with function of reducing fever and preparation method thereof
CN1133127A (en) Ginkgo leaf health care tea and production process thereof
CN103272207B (en) Traditional Chinese medicine for treating nerve headaches and preparation method of traditional Chinese medicine
CN1840132A (en) Tablet for treating climacteric syndrome
CN107854671A (en) A Na series anaesthetic intragastric floating sustained-release preparations and preparation method thereof
CN101317983A (en) Method for preparing capsule for nourishing Yin and suppressing Yang, discharging fire and pacifying the mind
CN101473940A (en) Functional health-care food for depression and preparation method thereof
CN1736449A (en) Powder for climacteric syndrome and its preparing process
CN103156976A (en) Traditional Chinese medicine dispersible tablet used for regulating menstruation and tonifying blood and preparation method thereof
CN1166397C (en) Medicine for treating cardiovascular and cerebrovascular system disease, apoplectic sequel
CN103961615B (en) A kind of Chinese medicine composition treating rhagadia manus et pedis and preparation thereof
CN102178891B (en) Chinese medicinal dispersible tablets for treating gastritis and preparation method thereof
CN100509048C (en) Jinwu Gutong tablet and preparing method thereof
CN1240655A (en) Face-nursing stigma croci tea and its making method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication